These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9987656)

  • 1. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
    Monge JM; Val-Bernal JF; Buelta L; García-Castrillo L; Asensio L
    Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear planimetry in renal-cell tumors.
    González-Cámpora R; González de Chaves FJ; Mora-Marin J; Rodriguez-González R; Utrilla-Alcolea JC; Rubí-Uría J; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):54-60. PubMed ID: 2025374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of morphometry as an independent prognostic factor in renal cell carcinoma.
    Ruiz JL; Hernández M; Martínez J; Vera C; Jimenez-Cruz JF
    Eur Urol; 1995; 27(1):54-7. PubMed ID: 7744143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system.
    Montironi R; Santinelli A; Pomante R; Mazzucchelli R; Colanzi P; Filho AL; Scarpelli M
    Virchows Arch; 2000 Jul; 437(1):82-9. PubMed ID: 10963384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases.
    Ficarra V; Righetti R; Martignoni G; D'Amico A; Pilloni S; Rubilotta E; Malossini G; Mobilio G
    Urol Int; 2001; 67(2):130-4. PubMed ID: 11490206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.
    van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
    Cancer; 1993 Nov; 72(9):2667-74. PubMed ID: 8402488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
    Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
    Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
    Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
    Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized nuclear morphometry and survival in renal cell carcinoma: comparison with other prognostic indicators.
    Delahunt B; Becker RL; Bethwaite PB; Ribas JL
    Pathology; 1994 Oct; 26(4):353-8. PubMed ID: 7892031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma.
    Pound CR; Partin AW; Epstein JI; Simons JW; Marshall FF
    Urology; 1993 Sep; 42(3):243-8. PubMed ID: 8379023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear morphometry in prognosis of renal adenocarcinoma.
    Gutierrez JL; Val-Bernal JF; Garijo MF; Buelta L; Portillo JA
    Urology; 1992 Feb; 39(2):130-4. PubMed ID: 1736504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
    Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
    J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
    Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma.
    Nativ O; Sabo E; Bejar J; Halachmi S; Moskovitz B; Miselevich I
    Br J Urol; 1996 Jul; 78(1):33-8. PubMed ID: 8795397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.